Search
ReShape Lifesciences Inc
RSLSAdd to Watchlist
3.920USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
10.29MMarket Cap
LossP/E TTM
More Details of ReShape Lifesciences Inc Company
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.
ReShape Lifesciences Inc Info
Ticker SymbolRSLS
Company nameReShape Lifesciences Inc
IPO dateOct 06, 2016
CEOMr. Paul F. Hickey
Number of employees17
Security typeOrdinary Share
Fiscal year-endOct 06
Address1001 Calle Amanecer
CitySAN CLEMENTE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code92673
Phone19494296680
Websitehttps://www.reshapelifesciences.com/obalon/
Ticker SymbolRSLS
IPO dateOct 06, 2016
CEOMr. Paul F. Hickey
Company Executives of ReShape Lifesciences Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
Mr. John Tincoff
Mr. John Tincoff
Director
Director
--
--
Mr. Robert Dickey
Mr. Robert Dickey
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Mohanjit Jolly
Mr. Mohanjit Jolly
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Krishna Gupta
Mr. Krishna Gupta
Chairman of the Board
Chairman of the Board
336.61K
--
Mr. Shiladitya Sengupta
Mr. Shiladitya Sengupta
Director
Director
92.00
--
Mr. Venkateswarlu (Venkat) Nelabhotla
Mr. Venkateswarlu (Venkat) Nelabhotla
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
+178.63%
Ms. Lori Courtney Mcdougal
Ms. Lori Courtney Mcdougal
Independent Director
Independent Director
--
--
Dr. Arda Minocherhomjee, Ph.D.
Dr. Arda Minocherhomjee, Ph.D.
Independent Director
Independent Director
--
--
Mr. Stash Pomichter
Mr. Stash Pomichter
Director
Director
--
--
FAQs
Who are the top five shareholders of ReShape Lifesciences Inc?
The top five shareholders of ReShape Lifesciences Inc are: Mr. Krishna Gupta
How many institutions hold shares of ReShape Lifesciences Inc (RSLS)?
As of 2026Q1, 34 institutions hold shares of ReShape Lifesciences Inc, with a combined market value of approximately 207.69K, accounting for 2.96% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 148618.00.